Is Aurobindo Pharma a good buy now?
Is Aurobindo Pharma Ltd undervalued or overvalued? The key valuation ratios of Aurobindo Pharma Ltd’s currently when compared to its past seem to suggest it is in the Fair zone.
What is the target of Aurobindo Pharma?
Date | Stock | Target |
---|---|---|
10 Feb 2022 | Aurobindo Pharma Ltd. | 759.00 |
10 Nov 2021 | Aurobindo Pharma Ltd. | 740.00 |
10 Nov 2021 | Aurobindo Pharma Ltd. | 780.00 |
09 Nov 2021 | Aurobindo Pharma Ltd. | 795.00 |
Will Auropharma go up?
quote is equal to 533.650 INR at 2022-09-17. Based on our forecasts, a long-term increase is expected, the “Aurobindo Pharma Ltd” stock price prognosis for 2027-09-10 is 579.553 INR. With a 5-year investment, the revenue is expected to be around +8.6%. Your current $100 investment may be up to $108.6 in 2027.
What is happening to Aurobindo Pharma?
Aurobindo Pharma Ltd. Promoters held 48.76 per cent stake in the company as of 30-Jun-2022, while FII and DII ownership stood at 20.71 per cent and 9.82 per cent, respectively. The Nifty Pharma index was trading 0.89 per cent down at 12569.45.
Is Aurobindo Pharma safe?
The FDA slapped Aurobindo Pharma, an Indian drugmaker, with a warning letter for failing to adequately investigate batch failures of active pharmaceutical ingredients and not evaluating the possible effect of changes on the intermediates and APIs manufactured at the site.
Can I invest in Aurobindo Pharma?
NSE 1.06 %. price can reach defined target. Aurobindo Pharma Ltd., incorporated in the year 1986, is a Large Cap company (having a market cap of Rs 32411.19 Crore) operating in Pharmaceuticals sector.
…
As on 04:04 PM | 07 Sep 2022.
Nifty Next 50 | 44,019.45 |
---|---|
25 Advance25 Decline | 93.70 (0.30%) |
Is Aurobindo Pharma Debt Free?
What Is Aurobindo Pharma’s Net Debt? As you can see below, Aurobindo Pharma had ₹23.7b of debt at March 2022, down from ₹49.7b a year prior. However, it does have ₹45.7b in cash offsetting this, leading to net cash of ₹22.0b.
Who is the owner of Aurobindo Pharma?
Ramprasad Reddy, Mr. K. Nityananda Reddy and a small group of highly committed professionals, Aurobindo Pharma was born of a vision. The company commenced operations in 1988-89 with a single unit manufacturing Semi-Synthetic Penicillin (SSP) at Pondicherry.
Is Aurobindo a good company?
Aurobindo Pharma has an overall rating of 3.7 out of 5, based on over 421 reviews left anonymously by employees. 69% of employees would recommend working at Aurobindo Pharma to a friend and 62% have a positive outlook for the business. This rating has decreased by -5% over the last 12 months.
Is Aurobindo safe?
What is the rank of Aurobindo Pharma in India?
2nd largest
Aurobindo Pharma is the 2nd largest pharmaceuticals company in India.
Is Auropharma large cap?
About. Aurobindo Pharma Ltd., incorporated in the year 1986, is a Large Cap company (having a market cap of Rs 32,059.63 Crore) operating in Pharmaceuticals sector. Aurobindo Pharma Ltd.
Which is the No 1 pharma company in India?
Sun Pharmaceutical Industries is the largest pharmaceutical company in India based on overall revenue. It is the fourth largest global specialty generic pharmaceutical company in the world.
Is Aurobindo Pharma debt Free?